United Kingdom: Pharmaceuticals Industry Guide

Datamonitor, March 2011, Pages: 79

The United Kingdom: Pharmaceuticals Industry Guide is an essential resource for top-level data and analysis covering the United Kingdom Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

Scope of the Report

- Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

- Provides textual analysis of the industry's prospects

- Incorporates in-depth five forces competitive environment analysis and scorecards

- Includes five-year forecasts for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

Highlights

The UK biotechnology market had total revenue of $6.2 billion in 2009, representing a compound annual growth rate (CAGR) of 2% for the period spanning 2005-2009.

The UK generics market had total revenue of $5 billion in 2009, representing a compound annual growth rate (CAGR) of 9.3% for the period spanning 2005-2009.

The UK OTC pharmaceuticals market generated total revenues of $4.5 billion in 2009, representing a compound annual growth rate (CAGR) of 2.4% for the period spanning 2005-2009.

The UK pharmaceuticals market had total revenue of $26.2 billion in 2010, representing a compound annual growth rate (CAGR) of 3.3% for the period spanning 2006-2010.

Why you should buy this report

- Spot future trends and developments

- Inform your business decisions

- Add weight to presentations and marketing materials

- Save time carrying out entry-level research

BIOTECHNOLOGY IN THE UNITED KINGDOM
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Five Forces Analysis
Market Forecasts
GENERICS IN THE UNITED KINGDOM
Market Overview
Market Value
Market Volume
Market Segmentation II
Five Forces Analysis
Market Forecasts
OTC PHARMACEUTICALS IN THE UNITED KINGDOM
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Market Share
Five Forces Analysis
Market Distribution
Market Forecasts
PHARMACEUTICALS IN THE UNITED KINGDOM
Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Market Share
Five Forces Analysis
Market Forecasts
MACROECONOMIC INDICATORS
APPENDIX
Data Research Methodology
About Datamonitor
Disclaimer

LIST OF TABLES
Table 1: United Kingdom biotechnology market value: $ billion, 2005–09
Table 2: United Kingdom biotechnology market segmentation I:% share, by value, 2009
Table 3: United Kingdom biotechnology Market Segmentation II: % share, by value, 2009
Table 4: United Kingdom biotechnology market value forecast: $ billion, 2009–14
Table 5: United Kingdom generics market value: $ billion, 2005–09
Table 6: United Kingdom generics market volume: volume penetration, 2005–09
Table 7: United Kingdom generics Market Segmentation II: % share, by value, 2009
Table 8: United Kingdom generics market value forecast: $ billion, 2009–14
Table 9: United Kingdom generics market volume forecast: volume penetration, 2009–14
Table 10: United Kingdom OTC pharmaceuticals market value: $ million, 2005–09
Table 11: United Kingdom OTC pharmaceuticals market segmentation I:% share, by value, 2009
Table 12: United Kingdom OTC pharmaceuticals Market Segmentation II: % share, by value, 2009
Table 13: United Kingdom OTC pharmaceuticals market share: % share, by value, 2009
Table 14: United Kingdom OTC pharmaceuticals market distribution: % share, by value, 2009
Table 15: United Kingdom OTC pharmaceuticals market value forecast: $ million, 2009–14
Table 16: United Kingdom pharmaceuticals market value: $ billion, 2006–10(e)
Table 17: United Kingdom pharmaceuticals market segmentation I:% share, by value, 2010(e)
Table 18: United Kingdom pharmaceuticals Market Segmentation II: % share, by value, 2010(e)
Table 19: United Kingdom pharmaceuticals market share: % share, by value, 2010(e)
Table 20: United Kingdom pharmaceuticals market value forecast: $ billion, 2010–15
Table 21: United Kingdom size of population (million), 2006–10
Table 22: United Kingdom GDP (constant 2000 prices, $ billion), 2006–10
Table 23: United Kingdom GDP (current prices, $ billion), 2006–10
Table 24: United Kingdom inflation, 2006–10
Table 25: United Kingdom consumer price index (absolute), 2006–10
Table 26: United Kingdom exchange rate, 2006–10

LIST OF FIGURES
Figure 1: United Kingdom biotechnology market value: $ billion, 2005–09
Figure 2: United Kingdom biotechnology market segmentation I:% share, by value, 2009
Figure 3: United Kingdom biotechnology Market Segmentation II: % share, by value, 2009
Figure 4: Forces driving competition in the biotechnology market in the United Kingdom, 2009
Figure 5: Drivers of buyer power in the biotechnology market in the United Kingdom, 2009
Figure 6: Drivers of supplier power in the biotechnology market in the United Kingdom, 2009
Figure 7: Factors influencing the likelihood of new entrants in the biotechnology market in the United Kingdom, 2009
Figure 8: Factors influencing the threat of substitutes in the biotechnology market in the United Kingdom, 2009
Figure 9: Drivers of degree of rivalry in the biotechnology market in the United Kingdom, 2009
Figure 10: United Kingdom biotechnology market value forecast: $ billion, 2009–14
Figure 11: United Kingdom generics market value: $ billion, 2005–09
Figure 12: United Kingdom generics market volume: volume penetration, 2005–09
Figure 13: United Kingdom generics Market Segmentation II: % share, by value, 2009
Figure 14: Forces driving competition in the generics market in the United Kingdom, 2009
Figure 15: Drivers of buyer power in the generics market in the United Kingdom, 2009
Figure 16: Drivers of supplier power in the generics market in the United Kingdom, 2009
Figure 17: Factors influencing the likelihood of new entrants in the generics market in the United Kingdom, 2009
Figure 18: Factors influencing the threat of substitutes in the generics market in the United Kingdom, 2009
Figure 19: Drivers of degree of rivalry in the generics market in the United Kingdom, 2009
Figure 20: United Kingdom generics market value forecast: $ billion, 2009–14
Figure 21: United Kingdom generics market volume forecast: volume penetration, 2009–14
Figure 22: United Kingdom OTC pharmaceuticals market value: $ million, 2005–09
Figure 23: United Kingdom OTC pharmaceuticals market segmentation I:% share, by value, 2009
Figure 24: United Kingdom OTC pharmaceuticals Market Segmentation II: % share, by value, 2009
Figure 25: United Kingdom OTC pharmaceuticals market share: % share, by value, 2009
Figure 26: Forces driving competition in the OTC pharmaceuticals market in the United Kingdom, 2009
Figure 27: Drivers of buyer power in the OTC pharmaceuticals market in the United Kingdom, 2009
Figure 28: Drivers of supplier power in the OTC pharmaceuticals market in the United Kingdom, 2009
Figure 29: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in the United Kingdom, 2009
Figure 30: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in the United Kingdom, 2009
Figure 31: Drivers of degree of rivalry in the OTC pharmaceuticals market in the United Kingdom, 2009
Figure 32: United Kingdom OTC pharmaceuticals market distribution: % share, by value, 2009
Figure 33: United Kingdom OTC pharmaceuticals market value forecast: $ million, 2009–14
Figure 34: United Kingdom pharmaceuticals market value: $ billion, 2006–10(e)
Figure 35: United Kingdom pharmaceuticals market segmentation I:% share, by value, 2010(e)
Figure 36: United Kingdom pharmaceuticals Market Segmentation II: % share, by value, 2010(e)
Figure 37: United Kingdom pharmaceuticals market share: % share, by value, 2010(e)
Figure 38: Forces driving competition in the pharmaceuticals market in the United Kingdom, 2010
Figure 39: Drivers of buyer power in the pharmaceuticals market in the United Kingdom, 2010
Figure 40: Drivers of supplier power in the pharmaceuticals market in the United Kingdom, 2010
Figure 41: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United Kingdom, 2010
Figure 42: Factors influencing the threat of substitutes in the pharmaceuticals market in the United Kingdom, 2010
Figure 43: Drivers of degree of rivalry in the pharmaceuticals market in the United Kingdom, 2010
Figure 44: United Kingdom pharmaceuticals market value forecast: $ billion, 2010–15

Customers who bought this item also bought

• UK Electronic Cigarettes Market 2011-2015
• The UK Health and Wellness Industry Outlook to 2017 - Robust Growth in Fitness and Nutraceutical Segment
• United Kingdom Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others
• United Kingdom Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices
• Future Horizons in the UK Tumor Marker Testing Market: Supplier Shares and Sales Forecasts for 40 Cancer Assays by Market Segment
• The UK Molecular Diagnostics and NAT Market: Sales Forecasts and Key Supplier Shares (DataPack)
• United Kingdom In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
• UK Blood Pressure Monitors Forecasts to 2018
• United Kingdom In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
• Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections